Intellex Acquires Expert by Big Village

We're thrilled to announce that Intellex has acquired Expert by Big Village, effective March 22, 2024. This strategic move enhances our capabilities and strengthens our commitment to delivering exceptional solutions to our customers.

Stay tuned for more updates on how this acquisition will benefit our clients and experts.

For inquiries or more information, please contact us at


Expert Details

New Drug Development and Approval

ID: 712197 Arizona, USA

Request Expert

Expert has extensive experience in complying with requirements of that part of the Act pertaining to drugs as implemented by the regulations of the FDA The requirements affect the development of drugs from the initial stages of screening to final market approval. Her experience specifically relates to the chemistry and manufacturing aspects, and comes from serving as an FDA reviewer and industry consultant.

Expert worked at the FDA for five years as a reviewer of new drugs, and has been a consultant for approximately 10 years since then, in assisting firms that develop new drugs in preparing the necessary documents to submit to the FDA. Assistance can be offered through all stages of the development process.

Expert has both industrial and government regulatory experience in meeting the requirements of good manufacturing practices that apply to manufacture of chemicals used as drug ingredients. She can offer assistance in the preparation of proper documentation in the form of drug master files or complete IND/NDA sections.

The preparation of chemistry and manufacturing data is extremely important to support the use of newly developed drugs in the early stages of investigation. Expert has worked with numerous firms in developing and presenting data that is evaluated by the FDA to determine the safety of the product for human use. This experience has covered a wide range of drugs, including simple inorganic materials, synthetic organic compounds, and recombinant DNA-produced materials.

Expert has prepared the detailed documents dealing with drug manufacturing that comprise a critical element in obtaining approval to market a new drug in the U.S. This has also included subsequent interaction and negotiation with the FDA staff to achieve agreement on mutually-acceptable standards. Her participation in the drug approval process, from within the FDA and as an industry consultant, provides a firm basis for assisting clients in planning for well-organized submissions.

Expert is experienced in the standards applied to the manufacture of drugs to assure that they comply with requirements for identity, strength, quality, and purity.


Year Degree Subject Institution
Year: 1971 Degree: PhD Subject: Physical Chemistry Institution: University of South Carolina
Year: 1964 Degree: BA Subject: Chemistry Institution: George Washington University

Work History

Years Employer Title Department
Years: 1985 to Present Employer: Undisclosed Title: Department:
Available upon request.
Years Employer Title Department
Years: 1981 to 1985 Employer: National Toxicology Program Title: Project Officer Department:
Available upon request.
Years Employer Title Department
Years: 1977 to 1981 Employer: FDA Title: Chemist in New Drug Evaluation Department:
Available upon request.
Years Employer Title Department
Years: 1971 to 1975 Employer: Arapahoe Chemicals Title: Health and Regulatory Affairs Chemist Department:
Available upon request.

Government Experience

Years Agency Role Description
Years: 1977 to 1981 Agency: Food and Drug Administration Role: New drug review chemist Description:
Years: 1981 to 1985 Agency: National Toxicology Program Role: Project officer Description:

Fields of Expertise

Request Expert

Dev Tool:

Request: expert/new-drug-development-and-approval
Matched Rewrite Rule: expert/([^/]+)(?:/([0-9]+))?/?$
Matched Rewrite Query: experts=new-drug-development-and-approval&page=
Loaded Template: single-experts.php